WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2020

Oct 30, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2020-10-29

Reporting Person: Winters Chad (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-29	Common Stock	F	47.00	$275.23	Disposed	544.8868	Direct

Footnotes

F1: Shares withheld solely for the purpose of satisfying tax liability due upon vesting of restricted stock award.